MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.New data from the ARCHER ...
Understand what the current ratio measures, why it matters, and how to use it to assess and improve short-term liquidity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback